Boston Scientific/Penumbra: Divestiture Buyer Sought for Embolization Coils Business to Address FTC Concerns
Boston Scientific (BSX) is seeking a divestiture buyer for an embolization coil business to get FTC clearance for its proposed $14.5 billion acquisition of Penumbra (PEN), sources familiar with the...
Oct 19, 2026
Read Now >

